Article

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes

2025-03-07

Abstract excerpt

The t(6;9)(p22.3;q34.1) translocation/DEK::NUP214 fusion protein defines a distinct subgroup of younger AML patients classified as a separate disease entity by the World Health Organization. DEK is a nuclear factor with multifunctional roles, including gene regulation, while its fusion partner, NUP214, plays a pivotal role in nuclear export by interacting with transport receptors such as XPO1. However, the precise...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ae097bbc-d2c0-5ae3-a3b4-4672099bde4e
DOI: 10.1101/2025.03.05.641116

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genesDOI 10.1101/2025.03.05.641116Read

DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genesSemantic proximity Read

XPO1-dependency of DEK::NUP214 leukemiaSemantic proximity Read

Gene regulation in t(6;9) DEK::NUP214 Acute Myeloid Leukemia resembles that of FLT3-ITD/NPM1 Acute Myeloid Leukemia but with an altered HOX/MEIS axisSemantic proximity Read

Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation.Semantic proximity Read

DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML)Semantic proximity Read

Targeting the Menin-KMT2A Axis in Acute Leukemia: From Epigenetic Dependency to Clinical Translation.Semantic proximity Read

Revumenib for patients with acute leukemia: a new tool for differentiation therapySemantic proximity Read

Deregulation of the HOXA9/MEIS1 axis in acute leukemia.Semantic proximity Read

Acute myeloid leukemia with del(9q) is characterized by frequent mutations of NPM1, DNMT3A, WT1 and low expression of TLE4.Semantic proximity Read

The Menin Inhibitor SNDX-5613 (revumenib) Leads to Durable Responses in Patients (Pts) with KMT2A-Rearranged or NPM1 Mutant AML: Updated Results of a Phase (Ph) 1 StudySemantic proximity Read

Fusion oncoproteins and cooperating mutations define disease phenotypes in<i>NUP98</i>-rearranged leukemiaSemantic proximity Read

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic TransformationSemantic proximity Read